MedTrace Logo

Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis

NCT06309355 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2025-12-18

No results posted yet for this study

Summary

This study is to evaluate the safety, tolerability, and pharmacokinetics of YR001 topical ointment in adult patients with mild to moderate atopic dermatitis

Conditions

Interventions

DRUG

YR001 ointment

The intervention is YR001 ointment on a range of body surface area for multiple topical administration

OTHER

Placebo

The intervention is Placebo on a range of body surface area for multiple topical administration

Sponsors & Collaborators

  • Hangzhou Yirui Pharmaceutical Technology Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-19
Primary Completion
2025-11-20
Completion
2025-11-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06309355 on ClinicalTrials.gov